Galderma’sNemluvio(nemolizumab)DemonstratesLong-TermDiseaseControlinPrurigoNodularisuptoThreeYears
===2026/2/27 17:48:31===
derma.com
+41 76 315 26 50
Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62
Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87
Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12
Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43
Nemluvio 3- year data - Prurigo NodularisNemluvio Media Factsheet
=*=*=*=*=*=
当前为第12/12页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页